Published in Br J Surg on July 01, 1991
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg (1999) 14.31
Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg (2005) 4.86
Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16
Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg (2003) 3.16
Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg (1992) 2.97
Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg (2000) 2.92
Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg (2004) 2.65
Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study. Ann Surg (2001) 2.40
The impact of margins on outcome after hepatic resection for colorectal metastasis. Ann Surg (2007) 2.23
Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg (1999) 2.22
Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg (1998) 2.10
Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancer. Ann Surg (1995) 1.81
Short-term and long-term outcomes after simultaneous resection of colorectal malignancies and synchronous liver metastases. World J Surg (2010) 1.52
Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg (2002) 1.42
Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol (2004) 1.28
Metastatic tumor doubling time: most important prehepatectomy predictor of survival and nonrecurrence of hepatic colorectal cancer metastasis. World J Surg (2004) 1.27
A new macroscopic classification predicts prognosis for patient with liver metastases from colorectal cancer. Ann Surg (1997) 1.22
Decision analysis for the cost-effective management of recurrent colorectal cancer. Ann Surg (2001) 1.19
Resection of colorectal liver metastases: is a resection margin of 3 mm enough? : a multicenter analysis of the GAST Study Group. World J Surg (2008) 0.99
Hepatectomy for colorectal liver metastases with macroscopic intrabiliary tumor growth. World J Surg (2006) 0.97
Mid-term results in otherwise treatment refractory primary or secondary liver confined tumours treated with selective internal radiation therapy (SIRT) using (90)Yttrium resin-microspheres. Eur Radiol (2006) 0.96
Surgery for colorectal liver metastases: The evolution of determining prognosis. World J Gastrointest Oncol (2013) 0.95
Prognostic significance of dysadherin expression in advanced colorectal carcinoma. Br J Cancer (2003) 0.94
Hepatic resection for colorectal metastases: can preoperative scoring predict patient outcome? World J Surg (2002) 0.94
Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysis. Ann Surg (2003) 0.93
Proposal of criteria to select candidates with colorectal liver metastases for hepatic resection: comparison of our scoring system to the positive number of risk factors. World J Gastroenterol (2006) 0.88
Outcomes after hepatic and pulmonary metastasectomies compared with pulmonary metastasectomy alone in patients with colorectal cancer metastasis to liver and lungs. World J Surg (2013) 0.88
Pre-hepatectomy prognostic staging to determine treatment strategy for colorectal cancer metastases to the liver. Langenbecks Arch Surg (2004) 0.87
Influence of preoperative chemotherapy on the intraoperative and postoperative course of liver resection for colorectal cancer metastases. World J Surg (2012) 0.83
Proposal of a new and simple staging system of colorectal liver metastasis. World J Gastroenterol (2006) 0.83
Long-term outcome after sequential resections of liver and lung metastases from colorectal carcinoma. HPB (Oxford) (2009) 0.83
Fas/CD95 signaling rather than angiogenesis or proliferative activity is a useful prognostic factor in patients with resected liver metastases from colorectal cancer. Int J Colorectal Dis (2005) 0.83
Patient selection for hepatic resection for metastatic colorectal cancer. J Gastrointest Oncol (2012) 0.82
Positive postoperative CEA is a strong predictor of recurrence for patients after resection for colorectal liver metastases. Ann Surg Oncol (2015) 0.82
Hepatic resection in stage IV colorectal cancer: prognostic predictors of outcome. Int J Colorectal Dis (2004) 0.80
Analysis of risk factors for the interval time, number and pattern of hepatic metastases from gastric cancer after radical gastrectomy. World J Gastroenterol (2008) 0.80
Prognostic significance of entrapped liver cells in hepatic metastases from colorectal cancer. Ann Surg (2000) 0.78
Prognostic factors and time-related changes influence results of colorectal liver metastases surgical treatment: a single-center analysis. World J Gastroenterol (2009) 0.78
Liver Metastases. Curr Treat Options Gastroenterol (1999) 0.78
Survival after resection of liver and lung colorectal metastases in the era of modern multidisciplinary therapy. Int J Colorectal Dis (2013) 0.77
Colorectal cancer: from epidemiology to current treatment. Libyan J Med (2006) 0.77
Liver resection after chemotherapy and tumour downsizing in patients with initially unresectable colorectal cancer liver metastases. HPB (Oxford) (2013) 0.75
Liver resection in a patient with concomitant thoraco-abdominal and cerebral aneurysms. HPB (Oxford) (2005) 0.75
History and present status of pulmonary metastasectomy in colorectal cancer. World J Gastroenterol (2014) 0.75
Comparison of Anatomical and Nonanatomical Hepatectomy for Colorectal Liver Metastasis: A Meta-Analysis of 5207 Patients. Sci Rep (2016) 0.75
Hepatic resection margin predicts survival in colorectal cancer with hepatic metastasis. Korean J Hepatobiliary Pancreat Surg (2012) 0.75
Assessment of pathological response to therapy using lipid mass spectrometry imaging. Sci Rep (2016) 0.75
TAC-101, a benzoic acid derivative, inhibits liver metastasis of human gastrointestinal cancer and prolongs the life-span. Clin Exp Metastasis (1998) 0.75
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med (1996) 22.46
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet (1998) 4.46
Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Engl J Med (1977) 3.45
ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology. Clin Nutr (2006) 2.89
Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care (1996) 2.80
Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer (1982) 2.71
Lack of effect of pregnancy on outcome of melanoma. For The World Health Organisation Melanoma Programme. Lancet (1991) 2.58
Stage I melanoma of the limbs: assessment of prognosis by levels of invasion and maximum thickness. Tumori (1978) 2.46
Effect of long-term adjuvant therapy with interferon alpha-2a in patients with regional node metastases from cutaneous melanoma: a randomised trial. Lancet (2001) 2.40
Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci (1986) 2.07
ESPEN Guidelines on Parenteral Nutrition: surgery. Clin Nutr (2009) 2.03
Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer (1992) 2.01
Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg (1999) 2.00
Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol (2007) 1.98
Temporal sequence of abnormal Doppler changes in the peripheral and central circulatory systems of the severely growth-restricted fetus. Ultrasound Obstet Gynecol (2002) 1.98
Home parenteral nutrition in adults: a european multicentre survey in 1997. ESPEN-Home Artificial Nutrition Working Group. Clin Nutr (1999) 1.77
c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases. J Clin Oncol (1996) 1.74
Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment. Ann Intern Med (1992) 1.72
Results of adjuvant interferon study in WHO melanoma programme. Lancet (1994) 1.62
Chronic hepatitis C and interferon alpha: conventional and cumulative meta-analyses of randomized controlled trials. Am J Gastroenterol (1999) 1.60
Morbidity and mortality after hepatic resection of metastases from colorectal cancer. Br J Surg (1995) 1.54
Kugel hernia repair: open "mini-invasive" technique. Personal experience on 620 patients. Hernia (2005) 1.54
Adequacy of margins of resection in gastrectomy for cancer. Ann Surg (1982) 1.52
Initial chemotherapy for primary resectable large-cell lymphoma of the stomach. Ann Oncol (1997) 1.51
Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg (1983) 1.50
Osteoblastic meningioma of the lateral ventricle. Case illustration. J Neurosurg (1999) 1.50
Thromboembolic risk in atrial flutter. The FLASIEC (FLutter Atriale Società Italiana di Ecografia Cardiovascolare) multicentre study. Eur Heart J (2001) 1.48
Prevention and treatment of central venous catheter sepsis by exchange via a guidewire. A prospective controlled trial. Ann Surg (1983) 1.48
Double versus single stapling technique in rectal anastomosis. Int J Colorectal Dis (1992) 1.47
Melatonin reduces the need for sedation in ICU patients: a randomized controlled trial. Minerva Anestesiol (2015) 1.46
Role of surgery in patients with primary non-Hodgkin's lymphoma of the stomach: an old problem revisited. Br J Surg (1993) 1.46
Patterns of failure following surgical resection of colorectal cancer liver metastases. Rationale for a multimodal approach. Ann Surg (1987) 1.46
Comparing reconstruction with Roux-en-Y to a pouch following total gastrectomy. J Am Coll Surg (1996) 1.44
Proceedings: The value of staging laparotomy in non-Hodgkin's lymphomas (with emphasis on the histiocytic type). Cancer (1974) 1.43
TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials. Radiology (1999) 1.42
No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group. J Hepatol (1995) 1.42
Vectorcardiographic evaluation of diabetic cardiomyopathy and of its contributing factors. Acta Diabetol Lat (1989) 1.39
Updating prognosis of cirrhosis by Cox's regression model using Child-Pugh score and aminopyrine breath test as time-dependent covariates. Ital J Gastroenterol Hepatol (1998) 1.39
Restoration of posterior aspect of rhabdosphincter shortens continence time after radical retropubic prostatectomy. J Urol (2006) 1.39
Combined modality treatment for primary gastrointestinal non-Hodgkin's lymphoma: the Milan Cancer Institute experience. Ann Oncol (1993) 1.37
Mortality in acute stroke with atrial fibrillation. The Italian Acute Stroke Study Group. Stroke (1991) 1.35
Stage I melanoma of the skin: evaluation of prognosis according to histologic characteristics. Cancer (1981) 1.33
Evaluating the therapeutic approach in pregnancies complicated by borderline glucose intolerance: a randomized clinical trial. Diabet Med (2005) 1.33
Pathogenesis and predictability of central venous catheter sepsis. Surgery (1982) 1.33
Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Support Care Cancer (2001) 1.32
Total versus subtotal gastrectomy: surgical morbidity and mortality rates in a multicenter Italian randomized trial. The Italian Gastrointestinal Tumor Study Group. Ann Surg (1997) 1.32
Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer. Cancer (1975) 1.31
Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovasc Surg (2005) 1.30
Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects. J Intern Med (2002) 1.29
New ulceration, new major amputation, and survival rates in diabetic subjects hospitalized for foot ulceration from 1990 to 1993: a 6.5-year follow-up. Diabetes Care (2001) 1.28
Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg (1985) 1.27
A multifactorial approach for the prognosis of patients with carcinoma of the stomach after curative resection. Surg Gynecol Obstet (1986) 1.27
Selecting high-risk early breast cancer patients: what to add to the number of metastatic nodes? Eur J Cancer (1996) 1.26
The prognostic value of lymphatic and blood vessel invasion in operable breast cancer. Cancer (1995) 1.25
Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain. Blood (2001) 1.24
The surgical management of elderly cancer patients; recommendations of the SIOG surgical task force. Eur J Cancer (2004) 1.23
Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer. Breast Cancer Res Treat (1986) 1.18
Pattern and management of recurrent hepatocellular carcinoma after liver transplantation. J Hepatobiliary Pancreat Surg (1998) 1.17
Analgesia and functional outcome after total knee arthroplasty: periarticular infiltration vs continuous femoral nerve block. Br J Anaesth (2010) 1.17
Early and five-year amputation and survival rate of diabetic patients with critical limb ischemia: data of a cohort study of 564 patients. Eur J Vasc Endovasc Surg (2006) 1.16
Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women. Hum Mol Genet (2000) 1.16
Mechanisms of impaired bone strength in type 1 and 2 diabetes. Nutr Metab Cardiovasc Dis (2010) 1.16
Subtotal versus total gastrectomy for cancer of the lower two-thirds of the stomach: a new approach to an old problem. Br J Surg (1986) 1.15
Surgical treatment of hepatic metastases from colorectal cancer. Ann Surg (1986) 1.14
Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group. Ann Oncol (2002) 1.13
Polymorphism of the aromatase gene in postmenopausal Italian women: distribution and correlation with bone mass and fracture risk. J Clin Endocrinol Metab (2001) 1.13
Prevalence of Helicobacter pylori infection in male patients with osteoporosis and controls. Dig Dis Sci (2005) 1.11
Increase of body weight during the first year of intensive insulin treatment in type 2 diabetes: systematic review and meta-analysis. Diabetes Obes Metab (2011) 1.10
High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity. Hepatology (2001) 1.10
Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer. Br J Cancer (2006) 1.10
Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis C. J Hepatol (2001) 1.09
Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease. Biochem Biophys Res Commun (1999) 1.08
Prognosis of patients after palliative surgical procedures for carcinoma of the stomach. Surg Gynecol Obstet (1987) 1.08
Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy. Cancer J Sci Am (1999) 1.08
Alendronate treatment in men with primary osteoporosis: a three-year longitudinal study. Calcif Tissue Int (2003) 1.07
A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma. N Engl J Med (1982) 1.06
Subclavian venous thrombosis due to indwelling catheters: a prospective study on 52 patients. JPEN J Parenter Enteral Nutr (1984) 1.05
Inflammatory cancer of the breast: analysis of 114 cases. J Surg Oncol (1981) 1.05
Long-term parenteral nutrition. Br Med J (1979) 1.05
Angiographic evaluation of peripheral arterial occlusive disease and its role as a prognostic determinant for major amputation in diabetic subjects with foot ulcers. Diabetes Care (1998) 1.05